The ABPI Code of Practice sets out the requirements the industry must comply with and supports companies’ commitment to self-regulation and to operate in a professional, ethical and transparent manner.
The Association of the British Pharmaceutical Industry (ABPI) commissioned Traverse, an independent research organisation, to undertake research into attitudes towards the Code of Practice for the industry.
Disclosure UK is part of a Europe-wide initiative to increase transparency between pharmaceutical companies and the doctors, nurses, pharmacists and other health professionals and organisations it works with.
As well as searching Disclosure UK you can also download the full dataset and Methodological Notes to explore the data further.
Prescription medicines are important therapeutic options which can be prescribed in order to prevent, treat or cure diseases and symptoms.
The ABPI recognises that there are occasions where the use of unlicensed medicines is required in the best medical interests of individual patients. As set out in medicines regulations and professional guidance, these circumstances should be limited to occasions where there is no suitable licensed...
The ABPI has produced this sourcebook to support pharmaceutical companies in working successfully and collaboratively with patients and patient organisations.
Our strategy sets out how the ABPI will deliver our commitments and make sure that patient engagement is consistently at the heart of our work.